Autologous progenitor cell therapy for the treatment of ischemic heart disease.
D054598:Blue Cross Blue Shield Insurance Plans; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods; D013673:Technology Assessment, Biomedical; D014182:Transplantation, Autologous / Q000009:adverse effects / Q000502:physiology; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration